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Intrusive thoughts of 
intentional harm to 
infants
Lawrence et al have written about intrusive 
and unwanted thoughts of intentional 
harm to infants in the context of maternal 
postnatal depression, anxiety, and obsessive 
compulsive disorder (OCD).1 We know that 
these thoughts are common in new parents, 
not only affecting almost 50% of mothers,2 
but also fathers. Their advice to health 
professionals is to normalise these thoughts 
for concerned parents with reassurance and 
to understand that by themselves the thoughts 
signify nothing sinister. The thoughts become 
significant when they interfere with the ability 
to live a normal life because the level of 
distress is so high, linked to the personal 
meaning of having the thought, rather than 
the specific content. These parents have no 
intention of harming their child. This is very 
different from a ‘delusion’, when a mother 
with psychosis or depression absolutely 
believes that her thoughts are real.
However, in the list of possible intrusive 
thoughts given, they do not include common 
examples of the most violent and repugnant 
thoughts that parents can experience, such 
as sexual abuse and cutting with knives. 
As a result, parents make elaborate plans 
to ensure these things cannot happen by 
avoiding changing nappies and refusing 
to cook, respectively. Not surprisingly, 
comorbidities with anxiety and depression 
are common. Parents are extremely unlikely 
to disclose these thoughts spontaneously 
because they are afraid that social services 
will be informed, and the child removed.
But health professionals are not used to 
hearing such awful thoughts expressed; a 
knee-jerk referral to social services is very 
possible. Within the context of perinatal 
OCD or depression and anxiety this would 
compound the damage and feed into the 
parents’ worst fears.
GPs need to understand the condition of 
perinatal OCD and make the right diagnosis 
so that the optimum treatment is offered 
and social services are not involved.3 
The treatment of choice is psychological 
cognitive behavioural therapy (CBT) 
with exposure and response prevention 
treatment (ERP). For more information, 
visit https://maternalocd.org/.
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PsyScan e-tool to 
support diagnosis 
and management of 
psychological problems 
in general practice
We read with great interest the article by 
Gidding et al about the effects of the e-tool 
PsyScan on patients with psychological 
problems in general practice.1 We agree that a 
tool is needed that can support management 
of these patients and we appreciate the effort 
in developing the PsyScan e-tool. However, 
we would like to discuss a few issues.
First, we approve of the randomisation 
method the authors used; however, patients 
were randomised before signing the detailed 
informed consent. We wonder if the initial 
assignment of patients in the intervention 
or control group may have influenced the 
decision to participate in the study. Was the 
number of participants who were excluded 
because they were not willing to sign the 
detailed consent similar in the intervention 
and control group? Participants who were 
assigned to the control group might be more 
likely to withdraw consent, because they could 
feel that participation had fewer benefits.
Second, participants in the intervention 
group first had to complete the three-
question distress screener. The score of this 
questionnaire was crucial for the advice and 
treatment the patients received. The validation 
of the three-question distress screener was 
investigated by Braam et al,2 although this 
was evaluated in a population of employees 
and not in the general practice population. 
What were the authors’ considerations for 
specifically choosing this questionnaire?
Third, the aim of the e-tool was to achieve 
more appropriate management of patients 
with psychological problems and provide an 
improvement of symptoms. The PsyScan 
resulted in a significant reduction of patient-
reported symptoms, although the number of 
the different GPs’ actions were quite similar in 
both groups, and most of the differences were 
not significant. In our opinion, these small 
differences may not be clinically relevant. Our 
question is: did the authors consider another 
working mechanism that can explain the 
shown symptom reduction after 12 months?
Fourth, we wonder if the authors could 
explain why, after 3 and 6 months, there 
were no significant differences, whereas 
after 12 months’ follow-up the difference 
in effects was present. Do the authors plan 
a longer-term follow-up, for example, after 
18 or 24 months?
In conclusion, the PsyScan is a relevant 
tool for the GP and results in a better 
understanding between patient and doctor.
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Author response
Thank you for your letter and your interest 
in PsyScan.1 We are glad to answer your 
questions. The participants were randomised 
before they had to sign the detailed informed 
consent. This was very important to us 
because we did not want the research to 
cause any delay in treatment, especially in 
the case of the participants in the control 
group. The numbers of participants who 
were excluded because they did not sign 
the informed consent were similar for both 
groups. This information is already given in 
the article, and we described that we used 
block randomisation and that the included 
numbers of participants were similar for 
both groups.
Second, the three-question distress 
screener has no direct influence on the 
advice and treatment the participants 
received. The diagnostic and therapeutic 
advices were based on the 4-Dimensional 
Symptom Questionnaire that has been 
researched extensively in general practice.
Third, we agree that Table 1 is crucial 
to understand the probable working 
mechanism of PsyScan. This table 
combined with the significant reduction 
of patient-reported symptoms indicates 
that PsyScan’s effect seems to be based 
on using more appropriate treatments for 
specific patients at specific times, resulting 
in better patient–treatment combinations.
Fourth, we ended the follow-up after 
12 months. The presence of a statistically 
significant effect only after 12 months 
could indicate that PsyScan creates longer-
lasting effects as opposed to usual care. 
As you pointed out, PsyScan indeed seems 
to create a better understanding between 
patient and GP.
Luc G Gidding,
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Skill-mix change and 
the general practice 
workforce challenge
The recent editorial on skill mix (‘Skill mix 
change and the general practice workforce 
challenge’)1 demonstrated a depressing 
recycling of familiar themes that have been 
around since at least the start of the century.2 
Inevitably, there will be major challenges 
when attempting to configure a system where 
there are conflicting demands of efficiency 
(what gives value for money?), equity (what is 
a fair distribution of our limited resources?), 
and affordability (how much have we got to 
spend?); that needs to be both resilient and 
innovative; and is free at the point of entry.
The editorial concludes with a more 
useful challenge, that ‘If changing skill-mix 
is the answer, what is the question?’ I’d like 
to suggest two. First, Is current healthcare 
research a self-sustaining activity that has 
an imperceptible impact compared with 
the resources invested in it? Second, why 
has a historically determined mix of skills 
continued that seeks to force the NHS into 
the disciplinary matrix rather than the more 
logical converse?
A more useful approach may be to view 
the meaningless policy imperatives such as 
transformation, modernisation, sustainability, 
and skill mix as defensive devices — gestures 
designed to avoid the harsh realities of our 
situation with its challenges, ambiguities, and 
paradoxes. At least we can then be in a better 
position to start an honest debate about the 
best way forward.
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WAP plan
I notice the plan starts with emollients 
etcetera before going on to topical steroids.1 
I understand this complies with NICE 
guidelines and has been normal practice 
since the sixties.
However, I have not been able to find any 
evidence for their efficacy and it seems that 
they are more of a tradition than a useful 
treatment. Would children do just as well by 
starting treatment on the most appropriate 
topical steroid?
Gerald Michael,
Retired GP, London. 
Email: gmm83@btinternet.com
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Author response
Dr Michael makes the very astute 
observation that, despite emollients forming 
the cornerstone of all guidelines and 
recommendations regarding the treatment of 
(atopic) eczema/dermatitis, the evidence base 
for their effectiveness is limited. He may be 
interested in the recently published Cochrane 
review by van Zureen and colleagues,1 
which, although limited by the quality and 
relevance of published trials to NHS general 
practice, does provide some reassurance that 
moisturisation is effective. What there is even 
less certainty about is whether one emollient 
is clinically or more cost-effective than 
another, and linked to this the acceptability 
of different types of emollients (lotion, cream, 
gel, and ointment being the main ones) to 
patients and their carers. This is the subject 
of an ongoing NIHR HTA-funded trial (‘Best 
Emollient for Eczema’, www.bristol.ac.uk/
bee-study), due to report in late 2020.
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